Skip to search.
 TSX Up 0.20% TSX Ventures Down 0.39%

Spectrum Pharmaceuticals, Inc. (SPPI)

-NasdaqGS
4.23 Up 0.20(4.96%) Dec 6, 4:00PM EST
|Pre-Market : 4.23 0.00 (0.00%) 5:20PM EST - Nasdaq Real Time Price
Prev Close:4.03
Open:N/A
Bid:N/A
Ask:6.20 x 1000
1y Target Est:9.00
Beta:1.25821
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:3.21 - 7.74
Volume:0
Avg Vol (3m):835,203
Market Cap:336.51M
P/E (ttm):N/A
EPS (ttm):-0.81
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
SPPIUp 4.96%336.51M
BIIBUp 0.32%63.35B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.98
Ex-Dividend Date:18-Dec-12

Analysts

Annual EPS Est (Dec-16) :-1.02
Quarterly EPS Est (Dec-16) :-0.29
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Spectrum Pharmaceuticals, Inc., a biotechnology company, develops and commercializes oncology and hematology drug products. The company markets six drug products, including FUSILEV for patients with metastatic colorectal cancer, rescue after high-... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback